washingtonpost.com
>
Health
>
Special Reports
>
Gelsinger Case
Jesse Gelsinger, 18, died in September 1999 after undergoing an experimental therapy. (File)
Gene Rule Proposed The Clinton administration proposed a new system for tracking dangerous side effects of experimental gene therapy treatments.
More News
FDA Seeks to Penalize Gene Scientist (Post, Dec. 12, 2000)
Penn Settles Gene Therapy Suit: University Pays Undisclosed Sum to Family of Teen Who Died (Post, Nov. 4, 2000)
Penn Researchers Sued in Gene Therapy Death: Teen's Parents Also Name Ethicist as Defendant (Post, Sept. 19, 2000)
FDA Faults Penn Animal Tests That Led to Fatal Human Trial: Genetic Research Killed Teenager (Post, July 12, 2000)
Penn Ends Gene Trials On Humans (Post, May 25, 2000)
FDA Stops Researcher's Human Gene Therapy Experiments (Post, March 2, 2000)
Gene Researchers Admit Mistakes, Deny Liability (Post, Feb. 15, 2000)
A Death Raises Questions of Ethics, Profit, Science (Post, Dec. 31, 1999)
Researchers Apologize in Gene Treatment (Post, Dec. 10, 1999)
Methods Faulted in Fatal Gene Therapy (Post, Dec. 8, 1999)
Researchers Claim No Error in Gene Therapy Death (Post, Dec. 2, 1999)
Calls Grow for More Oversight of Gene Therapy (Post, Nov. 24, 1999; 9:09 PM)
Hasty Decisions in the Race to a Cure?: Gene Therapy Study Proceeded Despite Safety, Ethics Concerns (Post, Nov. 21, 1999)
Gene Research Moves Toward Secrecy (Post, Nov. 3, 1999)
Firm Ordered to Stop Gene Therapy Studies (Post, Oct. 12, 1999)
Family's Debate Mirrored Scientists' on Gene Therapy Risk (Post, Sept. 30, 1999)
Teen Dies Undergoing Gene Therapy (Post, Sept. 29, 1999)
© 2002-2005 The Washington Post Company